• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS
Click for more information
0.00% 9.3¢

VECTUS BIOSYSTEMS LIMITED - Charts / Financials

Market Cap $4.948M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

refresh Created with Sketch. REFRESH
Last update - 10.32am 24/07/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
1 8.5¢ 15000   1 9.4¢ 14659

Directors & Senior Management

Mr. Robert Waring Company Secretary
Dr. Ronald Shnier Non-Executive Independent Chairman of the Board
Mr. Maurie Stang Non-Executive Deputy Chairman of the Board
Dr. Susan Margaret Pond Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
9.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.948M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 15000 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 14659 1
View Market Depth
Last trade - 10.09am 24/07/2024 (20 minute delay) ?

Top Stories

Opyl forms JV with UK and US consortium to bring products to the world

Medical technology and AI company Opyl Ltd is set to form a joint venture with UK and US consortium Xco to market its products.
Lithium production up 26%, revenue jumps 58% in June quarter for Pilbara Pilbara Minerals Ltd has reported a rise of 26% in production of hard rock lithium from its Pilgangoora operation.
NYSE-listed Alcoa Corp joins ASX through key JV acquisition Global frontrunner in bauxite, alumina and aluminium products Alcoa Corporation joins the Australian bourse today.
Macro Metals picks up 80% in Firebird's manganese plays; mining services operations to launch if decision to mine passed Macro Metals (ASX:M4M) – formerly Kogi Iron – has announced it's launched a mining services arm as its overall company mission expands.
Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic Magmatic Resources Ltd has seen the Lady Ilse prospect at its Wellington North increase significantly through recent aircore drilling work.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.